AR antagonists suppress cancer growth and induce cellular senescence that leads to cell cycle arrest in both androgen-dependent and castration resistant cell lines suggested as the major underlying mechanism to inhibit proliferation (Dai et al. 2017; Kokal et al. 2020; Shiota et al. 2022; Jin et al. 2024). This evidence concerns the gene AR and cancer.